Dimensional Fund Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-107,542
Closed -$14.7M – 3385
2020
Q3
$14.7M Buy
107,542
+7,522
+8% +$800K 0.01% 2019
2020
Q2
$9.66M Buy
100,020
+8,289
+9% +$691K ﹤0.01% 2216
2020
Q1
$4.31M Sell
91,731
-7,517
-8% -$482K ﹤0.01% 2471
2019
Q4
$7.23M Buy
99,248
+26,358
+36% +$1.6M ﹤0.01% 2478
2019
Q3
$3.8M Buy
72,890
+59,605
+449% +$3.17M ﹤0.01% 2692
2019
Q2
$665K Buy
+13,285
New +$647K ﹤0.01% 3140
2018
Q1
– Sell
-4,952
Closed -$208K – 3364
2017
Q4
$208K Hold
4,952
– – ﹤0.01% 3219
2017
Q3
$212K Buy
+4,952
New +$158K ﹤0.01% 3217

Dimensional Fund Advisors's MYOK Position: Q4 2020 in Review

Dimensional Fund Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 107,542 shares — an estimated $14.7M sold.

Dimensional Fund Advisors first reported a position in MYOK in Q3 2017 and held it in 8 quarters. The position peaked at $14.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Dimensional Fund Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Dimensional Fund Advisors sold 107,542 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $14.7M.
  • Dimensional Fund Advisors first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 8 quarters.
  • Dimensional Fund Advisors's MyoKardia, Inc. Common Stock position peaked at $14.7M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Dimensional Fund Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.